Gastritis is inflammation of the stomach lining that can be caused by H. pylori infection, autoimmune disorders, medications like NSAIDs, or other factors. It may cause no symptoms or lead to complications like ulcers or gastric cancer over time. Diagnosis involves endoscopy to visualize the stomach and biopsy to examine the tissue microscopically. Treatment depends on the underlying cause but aims to reduce inflammation and promote healing of the stomach. Surveillance endoscopy may be recommended for some high-risk groups to screen for precancerous changes or cancer.
This document discusses peptic ulcer disease, including its causes, symptoms, diagnosis and treatment. The predominant causes are Helicobacter pylori (H. pylori) infection and NSAID use. H. pylori infection is associated with 50-75% of ulcers in developed countries. Diagnosis involves invasive tests like endoscopy or noninvasive tests like the urea breath test. Treatment involves eradicating H. pylori, reducing acid levels with PPIs or H2 blockers, and lifestyle changes like quitting smoking.
Gastritis is inflammation of the stomach lining that has many potential causes. It can be acute, caused by infections like H. pylori, or chronic. Chronic gastritis is classified as type A, which affects the stomach body and is autoimmune, or type B, which is antral-predominant and usually caused by H. pylori. Treatment involves eradicating the underlying cause, like H. pylori, and treating complications. Rare forms include lymphocytic, eosinophilic, and Menetrier's disease, characterized by large folds in the stomach lining.
Peptic Ulcer Disease is caused by an imbalance between aggressive factors like acid and pepsin and protective mucosal defenses. The most common sites are the duodenum and stomach. Risk factors include H. pylori infection, NSAID use, smoking, stress, and Zollinger-Ellison syndrome. Patients present with epigastric pain, nausea, bleeding, or anemia. Endoscopy is the gold standard for diagnosis and allows visualization of ulcers. Treatment involves eradicating H. pylori if present, prescribing PPIs, and surgery for complications like bleeding or perforation. Complications can include bleeding, perforation, penetration, and malignant transformation if not properly treated.
1) Peptic ulcers are chronic lesions that occur in the stomach or first part of the duodenum due to an imbalance between damaging gastric acids and the mucosal defenses.
2) Common causes of peptic ulcers include infection with Helicobacter pylori bacteria, long-term use of NSAIDs, and excess stomach acid secretion.
3) Symptoms vary but often include epigastric pain that occurs one to three hours after eating and is relieved by food or antacids. Complications can include bleeding, perforation, or obstruction.
The document discusses Inflammatory Bowel Disease (IBD), including Ulcerative Colitis and Crohn's Disease, providing details on their etiology, clinical manifestations, investigations, medical and surgical management, and cancer risk. IBD is characterized by idiopathic intestinal inflammation that has genetic and environmental risk factors and can involve any part of the gastrointestinal tract. Management involves a multidisciplinary approach including medications, nutrition, and surgery.
Gastritis is inflammation of the stomach lining that can be acute or chronic. Acute gastritis is caused by factors like stress, alcohol, NSAIDs, and H. pylori infection, and presents with symptoms like abdominal pain. Chronic gastritis can be superficial or atrophic, and is often caused by long-term H. pylori infection. Diagnosis involves endoscopy with biopsy to check for signs of inflammation, atrophy, intestinal metaplasia, or dysplasia. Treatment focuses on removing triggers, eradicating H. pylori, and managing symptoms with antacids or PPIs. Patients with atrophic gastritis may also need B12 supplementation.
This document discusses peptic ulcer disease, including its causes, symptoms, diagnosis and treatment. The predominant causes are Helicobacter pylori (H. pylori) infection and NSAID use. H. pylori infection is associated with 50-75% of ulcers in developed countries. Diagnosis involves invasive tests like endoscopy or noninvasive tests like the urea breath test. Treatment involves eradicating H. pylori, reducing acid levels with PPIs or H2 blockers, and lifestyle changes like quitting smoking.
Gastritis is inflammation of the stomach lining that has many potential causes. It can be acute, caused by infections like H. pylori, or chronic. Chronic gastritis is classified as type A, which affects the stomach body and is autoimmune, or type B, which is antral-predominant and usually caused by H. pylori. Treatment involves eradicating the underlying cause, like H. pylori, and treating complications. Rare forms include lymphocytic, eosinophilic, and Menetrier's disease, characterized by large folds in the stomach lining.
Peptic Ulcer Disease is caused by an imbalance between aggressive factors like acid and pepsin and protective mucosal defenses. The most common sites are the duodenum and stomach. Risk factors include H. pylori infection, NSAID use, smoking, stress, and Zollinger-Ellison syndrome. Patients present with epigastric pain, nausea, bleeding, or anemia. Endoscopy is the gold standard for diagnosis and allows visualization of ulcers. Treatment involves eradicating H. pylori if present, prescribing PPIs, and surgery for complications like bleeding or perforation. Complications can include bleeding, perforation, penetration, and malignant transformation if not properly treated.
1) Peptic ulcers are chronic lesions that occur in the stomach or first part of the duodenum due to an imbalance between damaging gastric acids and the mucosal defenses.
2) Common causes of peptic ulcers include infection with Helicobacter pylori bacteria, long-term use of NSAIDs, and excess stomach acid secretion.
3) Symptoms vary but often include epigastric pain that occurs one to three hours after eating and is relieved by food or antacids. Complications can include bleeding, perforation, or obstruction.
The document discusses Inflammatory Bowel Disease (IBD), including Ulcerative Colitis and Crohn's Disease, providing details on their etiology, clinical manifestations, investigations, medical and surgical management, and cancer risk. IBD is characterized by idiopathic intestinal inflammation that has genetic and environmental risk factors and can involve any part of the gastrointestinal tract. Management involves a multidisciplinary approach including medications, nutrition, and surgery.
Gastritis is inflammation of the stomach lining that can be acute or chronic. Acute gastritis is caused by factors like stress, alcohol, NSAIDs, and H. pylori infection, and presents with symptoms like abdominal pain. Chronic gastritis can be superficial or atrophic, and is often caused by long-term H. pylori infection. Diagnosis involves endoscopy with biopsy to check for signs of inflammation, atrophy, intestinal metaplasia, or dysplasia. Treatment focuses on removing triggers, eradicating H. pylori, and managing symptoms with antacids or PPIs. Patients with atrophic gastritis may also need B12 supplementation.
This document discusses inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease. IBD is characterized by chronic inflammation of the gastrointestinal tract due to an inappropriate immune response. Ulcerative colitis only involves the colon, while Crohn's disease can involve any part of the GI tract. Risk factors include genetics, smoking status, and an altered gut microbiome. Symptoms vary depending on the location of inflammation. Treatment involves medications to induce and maintain remission, as well as surgery for complications or non-responsive cases.
This document provides an update on peptic ulcer disease. It discusses the pathophysiology, risk factors including H. pylori infection, clinical presentations, and current treatment strategies. Regarding treatment, it outlines the evolution of medical management from prior to discovering H. pylori to current antibiotic-based regimens. It also discusses management of complications like perforations, bleeding, and gastric outlet obstruction. For perforations, it compares conservative versus surgical management and describes different surgical repair techniques.
This document discusses H. pylori and peptic ulcers. It begins by introducing H. pylori as a gram-negative bacteria that causes gastritis and is associated with peptic ulcer disease and gastric cancer. It then discusses the epidemiology, pathogenesis, diseases associated with H. pylori infection including gastritis, peptic ulcers, gastric cancer, and MALT lymphoma. The document outlines methods for diagnosing and treating H. pylori, as well as managing peptic ulcer disease through lifestyle changes, medication, and occasionally surgery for refractory cases.
Peptic ulcer disease is defined as a discontinuity in the gastric or duodenal mucosa exposed to acid and pepsin secretion. Common causes include H. pylori infection, NSAID use, and stress. H. pylori infection is associated with 95% of duodenal ulcers and 80% of gastric ulcers. NSAID use inhibits prostaglandins, which protect the gastric mucosa. Treatment involves antibiotics to eradicate H. pylori, PPIs to reduce acid secretion, and medications to protect the gastric lining such as sucralfate. Triple therapy with a PPI and two antibiotics is the standard treatment to eradicate H. pylori.
Peptic ulcer disease causes and treatmentAbu Bakar
Peptic ulcer disease is defined as a discontinuity in the gastric or duodenal mucosa exposed to acid and pepsin secretion. Common causes include H. pylori infection, NSAID use, and stress. H. pylori infection is associated with 95% of duodenal ulcers and 80% of gastric ulcers. NSAID use inhibits prostaglandins, which protect the gastric mucosa. Treatment involves antibiotics to eradicate H. pylori, PPIs to reduce acid secretion, and medications to protect the gastric lining such as sucralfate. Triple therapy with a PPI and two antibiotics is the standard treatment to eradicate H. pylori.
The document summarizes information about gastric cancer including its location in the stomach, classification, risk factors, diagnosis, staging, and management. Some key points are:
- Gastric cancer develops through a sequence of changes called the Correa cascade triggered by H. pylori infection and other environmental factors.
- Classification includes anatomical staging, histological subtypes, and molecular markers which guide treatment and prognosis.
- Risk increases with age, smoking, diet, and genetic conditions. Screening occurs in high-risk areas like Japan.
- Diagnosis is by endoscopy and biopsy. Staging involves blood tests, imaging, and endoscopic ultrasound.
- Treatment depends on stage but may include surgery,
This document discusses gastrointestinal tuberculosis. It begins by noting the difficulty in diagnosing abdominal tuberculosis and provides epidemiological data on tuberculosis infections and deaths worldwide. It then describes the different types of abdominal tuberculosis that can occur, including tuberculous lymphadenopathy, peritoneal tuberculosis, and tuberculosis of the liver, pancreas, and other organs. The document discusses the clinical manifestations and investigations used to diagnose abdominal tuberculosis, including ascitic fluid analysis, imaging, and endoscopy. It emphasizes that a high index of suspicion is needed to diagnose abdominal tuberculosis.
LOWER GI HEMORRHAGE- PLAYLIST OF 6 VIDEOS
Dear Viewers,
Greetings from “Surgical Educator”.
I have made a playlist for Lower GI Hemorrhage which consists of six videos on various causes of Lower GI Hemorrhage. They are Introduction, diverticular disease, haemorrhoids, fissure-in-ano, colorectal carcinoma and inflammatory bowel disease. If you watch all these videos together you will become confident to tackle the clinical problem of Lower GI Hemorrhage. You can watch these videos in the following link: https://www.youtube.com/playlist…
Thank you for watching the videos.
A peptic ulcer is a break in the stomach or duodenal lining that extends into deeper layers. Helicobacter pylori (H. pylori) infection and NSAID use are the most important risk factors. Common symptoms include recurrent epigastric pain relieved by food or antacids. Endoscopy is required for diagnosis and management. Eradication of H. pylori using PPIs and antibiotics is recommended to promote healing and prevent complications like bleeding. Surgery is only required for complications when medical management fails.
This document provides an overview of peptic ulcers, including:
1. It defines peptic ulcers as erosions of the GI mucosa caused by digestive acids, most commonly occurring in the stomach and duodenum.
2. The pathophysiology of peptic ulcers is described as an imbalance between aggressive factors like acid and pepsin and protective mechanisms of the mucosa.
3. Treatment options for peptic ulcers include medications to reduce acid secretion, eradicate H. pylori infections, and surgery for complicated cases. Goals of treatment are to heal ulcers and prevent recurrence through lifestyle changes.
This document provides an overview of peptic ulcers, including:
1. It defines peptic ulcers as erosions of the GI mucosa caused by digestive acids, most commonly occurring in the stomach and duodenum.
2. The pathophysiology of peptic ulcers is described as an imbalance between aggressive factors like acid and pepsin and protective mechanisms of the mucosa.
3. Treatment options for peptic ulcers include medications to reduce acid secretion, eradicate H. pylori infections, and surgery for complicated cases. Goals of treatment are to heal ulcers and prevent recurrence through lifestyle changes.
science has an evolving nature. what happened today may not be tomorrow, what is not today may happen tomorrow.
No one is complete so reading and thinking may open the door to the hidden ground.
This topic helps you , how to approach a patient having peptic ulcer disease and how to diagnose finally how to end up with treatment. Peptic ulcer disease a chronic disease of stomach and duodenum where the protective layer of stomach and duodenum weakens by many factors most common is H Pylori infection. Infection of H Pylori cause ulcer over time.
This document summarizes different types of gastritis and gastric disorders. It defines gastritis as inflammation of the stomach lining and gastropathy as epithelial cell damage without inflammation. It then classifies gastritis as acute or chronic and discusses various causes including H. pylori infection, NSAIDs, stress, and autoimmune conditions. It also describes different metaplastic and hyperplastic gastropathies such as Menetrier's disease and Zollinger-Ellison syndrome.
Peptic ulcers are lesions that occur in areas of the gastrointestinal tract exposed to stomach acid. Risk factors include H. pylori infection and NSAID use. Clinical features include recurrent abdominal pain related to food. Diagnosis involves endoscopy with biopsy or breath/stool tests for H. pylori. Management involves eradicating H. pylori with triple therapy antibiotics and PPIs. Surgery is rarely needed and reserved for complications like perforation or bleeding.
This document discusses peptic ulcers, including their causes, symptoms, diagnosis, and treatment. Peptic ulcers are abnormalities in the gastrointestinal tract caused by damage from stomach acid. The most common causes are infection with Helicobacter pylori bacteria and long-term use of nonsteroidal anti-inflammatory drugs. Common symptoms include abdominal pain, nausea, and vomiting of blood. Diagnosis involves tests to detect H. pylori infection and endoscopy to view the ulcers. Treatment focuses on eradicating H. pylori with antibiotics, reducing stomach acid with proton pump inhibitors or H2 blockers, and protecting the lining with sucralfate.
This is comprehensive Presentation about IBD, its Classification, major subtypes, eitology, genetics, presentation, diagnosis and treatment.
it Includes Both Crohn's Disease And Ulcerative Colitis in detail
Pathology, Diagnosis, Medical Therapy, Surgical Management of Both the diseases are described
UC is an idiopathic IBD that affects the colonic mucosa.
Hallmark of UC is bloody diarrhea often with prominent symptoms of rectal urgency and tenesmus.
The clinical course is marked by exacerbations and remissions.
The diagnosis of UC is suspected on clinical grounds and supported by the appropriate findings on
Proctosigmoidoscopy or colonoscopy
Biopsy
By negative stool examination for infectious causes
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
This document discusses inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease. IBD is characterized by chronic inflammation of the gastrointestinal tract due to an inappropriate immune response. Ulcerative colitis only involves the colon, while Crohn's disease can involve any part of the GI tract. Risk factors include genetics, smoking status, and an altered gut microbiome. Symptoms vary depending on the location of inflammation. Treatment involves medications to induce and maintain remission, as well as surgery for complications or non-responsive cases.
This document provides an update on peptic ulcer disease. It discusses the pathophysiology, risk factors including H. pylori infection, clinical presentations, and current treatment strategies. Regarding treatment, it outlines the evolution of medical management from prior to discovering H. pylori to current antibiotic-based regimens. It also discusses management of complications like perforations, bleeding, and gastric outlet obstruction. For perforations, it compares conservative versus surgical management and describes different surgical repair techniques.
This document discusses H. pylori and peptic ulcers. It begins by introducing H. pylori as a gram-negative bacteria that causes gastritis and is associated with peptic ulcer disease and gastric cancer. It then discusses the epidemiology, pathogenesis, diseases associated with H. pylori infection including gastritis, peptic ulcers, gastric cancer, and MALT lymphoma. The document outlines methods for diagnosing and treating H. pylori, as well as managing peptic ulcer disease through lifestyle changes, medication, and occasionally surgery for refractory cases.
Peptic ulcer disease is defined as a discontinuity in the gastric or duodenal mucosa exposed to acid and pepsin secretion. Common causes include H. pylori infection, NSAID use, and stress. H. pylori infection is associated with 95% of duodenal ulcers and 80% of gastric ulcers. NSAID use inhibits prostaglandins, which protect the gastric mucosa. Treatment involves antibiotics to eradicate H. pylori, PPIs to reduce acid secretion, and medications to protect the gastric lining such as sucralfate. Triple therapy with a PPI and two antibiotics is the standard treatment to eradicate H. pylori.
Peptic ulcer disease causes and treatmentAbu Bakar
Peptic ulcer disease is defined as a discontinuity in the gastric or duodenal mucosa exposed to acid and pepsin secretion. Common causes include H. pylori infection, NSAID use, and stress. H. pylori infection is associated with 95% of duodenal ulcers and 80% of gastric ulcers. NSAID use inhibits prostaglandins, which protect the gastric mucosa. Treatment involves antibiotics to eradicate H. pylori, PPIs to reduce acid secretion, and medications to protect the gastric lining such as sucralfate. Triple therapy with a PPI and two antibiotics is the standard treatment to eradicate H. pylori.
The document summarizes information about gastric cancer including its location in the stomach, classification, risk factors, diagnosis, staging, and management. Some key points are:
- Gastric cancer develops through a sequence of changes called the Correa cascade triggered by H. pylori infection and other environmental factors.
- Classification includes anatomical staging, histological subtypes, and molecular markers which guide treatment and prognosis.
- Risk increases with age, smoking, diet, and genetic conditions. Screening occurs in high-risk areas like Japan.
- Diagnosis is by endoscopy and biopsy. Staging involves blood tests, imaging, and endoscopic ultrasound.
- Treatment depends on stage but may include surgery,
This document discusses gastrointestinal tuberculosis. It begins by noting the difficulty in diagnosing abdominal tuberculosis and provides epidemiological data on tuberculosis infections and deaths worldwide. It then describes the different types of abdominal tuberculosis that can occur, including tuberculous lymphadenopathy, peritoneal tuberculosis, and tuberculosis of the liver, pancreas, and other organs. The document discusses the clinical manifestations and investigations used to diagnose abdominal tuberculosis, including ascitic fluid analysis, imaging, and endoscopy. It emphasizes that a high index of suspicion is needed to diagnose abdominal tuberculosis.
LOWER GI HEMORRHAGE- PLAYLIST OF 6 VIDEOS
Dear Viewers,
Greetings from “Surgical Educator”.
I have made a playlist for Lower GI Hemorrhage which consists of six videos on various causes of Lower GI Hemorrhage. They are Introduction, diverticular disease, haemorrhoids, fissure-in-ano, colorectal carcinoma and inflammatory bowel disease. If you watch all these videos together you will become confident to tackle the clinical problem of Lower GI Hemorrhage. You can watch these videos in the following link: https://www.youtube.com/playlist…
Thank you for watching the videos.
A peptic ulcer is a break in the stomach or duodenal lining that extends into deeper layers. Helicobacter pylori (H. pylori) infection and NSAID use are the most important risk factors. Common symptoms include recurrent epigastric pain relieved by food or antacids. Endoscopy is required for diagnosis and management. Eradication of H. pylori using PPIs and antibiotics is recommended to promote healing and prevent complications like bleeding. Surgery is only required for complications when medical management fails.
This document provides an overview of peptic ulcers, including:
1. It defines peptic ulcers as erosions of the GI mucosa caused by digestive acids, most commonly occurring in the stomach and duodenum.
2. The pathophysiology of peptic ulcers is described as an imbalance between aggressive factors like acid and pepsin and protective mechanisms of the mucosa.
3. Treatment options for peptic ulcers include medications to reduce acid secretion, eradicate H. pylori infections, and surgery for complicated cases. Goals of treatment are to heal ulcers and prevent recurrence through lifestyle changes.
This document provides an overview of peptic ulcers, including:
1. It defines peptic ulcers as erosions of the GI mucosa caused by digestive acids, most commonly occurring in the stomach and duodenum.
2. The pathophysiology of peptic ulcers is described as an imbalance between aggressive factors like acid and pepsin and protective mechanisms of the mucosa.
3. Treatment options for peptic ulcers include medications to reduce acid secretion, eradicate H. pylori infections, and surgery for complicated cases. Goals of treatment are to heal ulcers and prevent recurrence through lifestyle changes.
science has an evolving nature. what happened today may not be tomorrow, what is not today may happen tomorrow.
No one is complete so reading and thinking may open the door to the hidden ground.
This topic helps you , how to approach a patient having peptic ulcer disease and how to diagnose finally how to end up with treatment. Peptic ulcer disease a chronic disease of stomach and duodenum where the protective layer of stomach and duodenum weakens by many factors most common is H Pylori infection. Infection of H Pylori cause ulcer over time.
This document summarizes different types of gastritis and gastric disorders. It defines gastritis as inflammation of the stomach lining and gastropathy as epithelial cell damage without inflammation. It then classifies gastritis as acute or chronic and discusses various causes including H. pylori infection, NSAIDs, stress, and autoimmune conditions. It also describes different metaplastic and hyperplastic gastropathies such as Menetrier's disease and Zollinger-Ellison syndrome.
Peptic ulcers are lesions that occur in areas of the gastrointestinal tract exposed to stomach acid. Risk factors include H. pylori infection and NSAID use. Clinical features include recurrent abdominal pain related to food. Diagnosis involves endoscopy with biopsy or breath/stool tests for H. pylori. Management involves eradicating H. pylori with triple therapy antibiotics and PPIs. Surgery is rarely needed and reserved for complications like perforation or bleeding.
This document discusses peptic ulcers, including their causes, symptoms, diagnosis, and treatment. Peptic ulcers are abnormalities in the gastrointestinal tract caused by damage from stomach acid. The most common causes are infection with Helicobacter pylori bacteria and long-term use of nonsteroidal anti-inflammatory drugs. Common symptoms include abdominal pain, nausea, and vomiting of blood. Diagnosis involves tests to detect H. pylori infection and endoscopy to view the ulcers. Treatment focuses on eradicating H. pylori with antibiotics, reducing stomach acid with proton pump inhibitors or H2 blockers, and protecting the lining with sucralfate.
This is comprehensive Presentation about IBD, its Classification, major subtypes, eitology, genetics, presentation, diagnosis and treatment.
it Includes Both Crohn's Disease And Ulcerative Colitis in detail
Pathology, Diagnosis, Medical Therapy, Surgical Management of Both the diseases are described
UC is an idiopathic IBD that affects the colonic mucosa.
Hallmark of UC is bloody diarrhea often with prominent symptoms of rectal urgency and tenesmus.
The clinical course is marked by exacerbations and remissions.
The diagnosis of UC is suspected on clinical grounds and supported by the appropriate findings on
Proctosigmoidoscopy or colonoscopy
Biopsy
By negative stool examination for infectious causes
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
2. What is gastritis?
• A symptom complex
• Endoscopic appearance of the stomach
• Microscopic inflammation of the
stomach
3. Gastritis: definitions
• Gastritis: inflammation associated with
epithelial cell damage and regeneration
• Gastropathy: mucosal injury without
inflammation
• Atrophy: loss of normal mucosal glands
• Metaplasia: change in epithelial cell
types
4. gastritis
• There is not a close relationship
between clinical symptoms and
histologic gastritis
• Although gastritis may not produce
symptoms, its complications do.
5. Gastritis: correlation of endoscopic
and histologic findings
• 98 patients with endoscopic mucosal
changes attributed to gastritis: 27 had normal
biopsy
• 69 patients with normal endoscopic
appearance: 63% had histologic evidence of
gastritis
• Interobserver variability for some features of
gastritis (Gastrointest Endosc 1995;42:420)
6.
7. Chronic nonspecific Gastritis
classification
• Nonatrophic- type B
• atrophic - type A
• H. pylori
• Antrum > corpus
• Diffuse antral predominant
gastritis
• AUTOIMMUNE (body, fundus)
– Diffuse corporal atrophic
gastritis
– Autoimmune metaplastic
atrophic gastritis
• MULTIFOCAL (H. pylori, antrum
= corpus)
– Multifocal atrophic gastritis
10. H. Pylori gastritis
• Acute
• Chronic
– Antral predominant gastritis, also called
type B, nonatrophic, diffuse antral
predominant gastritis
– Atrophic gastritis, also called type A,
multifocal atrophic gastritis, metaplastic
atrophic gastritis
11. Clinical significance of H pylori gastritis
• Acute
– May be symptomatic with epigastric pain, nausea and
vomiting
• Antral predominant gastritis
– Duodenal ulcer
• Atrophic gastritis
– Intestinal metaplasia
– Gastric ulcer
– Gastric adenocarcinoma
12. Where to biopsy for H. pylori
• 2 from antrum
• 2 from gastric body
• 1 from incisura: site most likely to show
atrophic gastritis and premalignant
dysplasia
14. Endoscopic findings of H.
pylori
• No distinct endoscopic
pattern
• Normal
• Red streaks in antrum
• Erosions and ulcerations
• Hypertrophy, atrophy
15. Autoimmune metaplastic atrophic
gastritis
• Immune response directed against parietal
cells and intrinsic factor
• 3x more common in women
• Autosomal dominant disorder
• Northern European
• Associated with other autoimmune
disorders: Hashimotos thyroiditis and
vitiligo
16. Autoimmune metaplastic atrophic
gastritis: endoscopic findings
• Appearance of multiple polyps
• Absent or inconspicous rugae in body
and fundus
• Submucosal blood vessels visible
through thin atrophic overlying mucosa
• Usually no antral involvement
18. Intestinal metaplasia
• Eventually atrophic glands are replaced
by metaplastic epithelium
• H. pylori: Intestinal metaplasia develops
at a rate of 1-2% per annum to yield a
lifetime risk of 50-75%
19. Patchy intestinal metaplasia, paler than surrounding mucosa, in
the antrum of 52 year old woman with dyspepsia. Test for H.
pylori was positive
22. H. Pylori and peptic ulcer disease
• Gastritis is found in virtually all patients
infected with H. pylori
• In the United States, 80% of pts with DU and
60% with GU are associated with H. pylori
• Fewer than 20% of people with H. p ever
develop PUD
• H. p. Rx with antibiotics dramatically
decreases ulcer recurrance rate
24. Gastritis and gastric cancer
• Adenocarcinoma
– H pylori
– autoimmune
• MALT: H. pylori
• Carcinoid: autoimmune
25. Gastritis and gastric cancer:
H pylori and adenocarcinoma
• 2nd most common cancer worldwide
• in US: 8th cancer related mortality in men and 10th in
women
• Decreased incidence of gastric adenocarcinoma in western
populations parallels decrease in prevalence of H pylori
• H pylori infected individuals have 2-10x increased incidence
of gastric cancer
• 36 and 47% of all gastric cancers in developed and
developing countries respectively are attributable to H pylori
• Multifactorial
27. Chronic gastritis and gastric
adenocarcinoma
• Increased risk with intestinal
metaplasia; not known if cancer arises
from intestinal metaplasia or whether it
represents a marker of increased risk
• Autoimmune gastritis: 3-18x increased
risk of gastric adenocarcinoma
28. Gastritis and gastric cancer
MALToma
• Low grade B cell lymphoma
• Mucosal associated lymphoid tissue
29. MALToma
• associated with chronic H. pylori infection in more
than 90% of cases
• Primary gastric lymphoma accounts for 3% of
gastric neoplasms and 10% of lymphomas
• 50% of gastric lymphomas are MALT
• H. pylori induces mucosal inflammatory reaction,
lymphoid follicles -> B cell monoclonal cells ->
autonomous uncontrolled growth
30. • Gastric MALToma: dense monotonous
lymphoid infiltrate in the lamina propria
31. Autoimmune gastritis and carcinoid
tumors
• Loss of parietal cell mass - >
hypochlorhydria -> G cell hyperplasia
and hypergastrinemia -> chronic
stimulation of enterochromaffin like cells
by gastrin
33. What to do about gastric cancer and
gastritis: look for H pylori ?
Unknown if treatment for H pylori decreases
risk of gastric cancer
• Studies are difficult because of long cancer
development process that may take several
decades
34. What to do about gastritis and gastric
cancer: look for H pylori ?
• some studies show improvement in inflammation and intestinal
metaplasia
• 2 studies show improvement in gastritis and superficial epithelial
damage but no improvement in intestinal metaplasia or atrophy
• 1 study from China: healthy H. pylori carriers, treated and followed
for 7.5 years. No overall decrease in gastric cancer. Subgroup of
patients with no precancerous lesions on presentation did have
decreased gastric cancer risk. (JAMA 2004;291:187)
35. What to do about gastritis and cancer risk:
look for H. pylori
• If you find H. pylori: eradication should be
considered because it is a carcinogen
(ASGE)
• Insufficient evidence to recommend
screening asymptomatic patients for H.
pylori to prevent gastric cancer (up to date)
• Consider testing first degree relatives of
patients with noncardia gastric cancer (Mayo)
36. What to do about gastritis and cancer risk:
surveillance scope for dysplasia or cancer?
ASGE guidelines
• Pernicious anemia: Single endoscopy should be
performed to identify carcinoid and gastric cancer
• Endoscopic surveillance of gastric intestinal
metaplasia has not been extensively studied in the
United states and therefore cannot be uniformly
recommended
• Patients at increased risk for gastric cancer due to
ethnic background or family history may benefit
from surveillance
37. What to do about gastritis and cancer risk:
dysplasia
• Low grade dysplasia: surveillance EGD
every 3 months for at least 1 year with
topographic mapping biopsy strategy
• High grade dysplasia: consider
endoscopic resection or gastrectomy
38. MALToma
• H. pylori therapy is useful in patients
with localized, mucosal or submucosal,
nonbulky, flat disease (without
metastasis, LN, or diffuse large B cell
lymphoma)
• Only 10% of lymphoma patients
• 50-90% complete remission
44. Gastropathy
• Hemorrhagic or erosive lesions
• Caused by irritants such as medications
or reduction in mucosal blood flow
• NSAIDs, alcohol, trauma, sepsis
• Disruption of normal protective barrier:
mucin, bicarbonate, epithelium, PG
45. Gastropathy
• Endoscopic findings
– Acute: may be diffuse (NSAIDs and
alcohol) or confined to body and fundus
(stress)
– Chronic: usually antrum
49. Foveolar hyperplasia
• Tortuous, corkscrew
appearance
• Marker of increased
epithelial cell
turnover
• Chemical injury and
H pylori gastritis
50. Bile reflux gastropathy
• Often occurs after gastric
surgery
• Asymptomatic or
abdominal pain, emesis
and weight loss
• Erosions, redness, bile
staining of gastric
mucosa
• Treatment: sulcralfate,
ursodeoxycholic acid,
surgery